Proteus Digital Health is a biotechnology company focused on creating a new category of pharmaceuticals: Digital Medicines, which include drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making, and data analytics to serve the needs of doctors and health systems.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/15/2016 | Series H | $50MM | $xx.xx | $163.79B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,164,557
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/29/2014 | Series G | $172MM | $xx.xx | $120B | Orbimed & Sailing Capital | |
Price per Share
$xx.xx
Shares Outstanding
13,089,802
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Orbimed & Sailing Capital
|
||||||
05/02/2013 | Series F | $62.5MM | $xx.xx | $42.67B | Novartis Venture Fund, On Semiconductor, Oracle, Otsuka Pharmaceutical, Sino Portfolio, Sutter Health Master Trust | |
Price per Share
$xx.xx
Shares Outstanding
10,775,862
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Novartis Venture Fund, On Semiconductor, Oracle, Otsuka Pharmaceutical, Sino Portfolio, Sutter Health Master Trust
|
||||||
12/26/2009 | Series E | $35MM | $xx.xx | $31.55B | Adams Street Partners, Ew Healthcare Partners, Frazier Healthcare Partners, Novartis Venture Fund, Spring Ridge Ventures, The Carlyle Group | |
Price per Share
$xx.xx
Shares Outstanding
6,034,483
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Ew Healthcare Partners, Frazier Healthcare Partners, Novartis Venture Fund, Spring Ridge Ventures, The Carlyle Group
|
||||||
10/15/2008 | Series D | $32.05MM | $xx.xx | $26.03B | Adams Street Partners, Ew Healthcare Partners, Itochu Technology Ventures, Kaiser Permanente Ventures, Medtronic, Others | |
Price per Share
$xx.xx
Shares Outstanding
5,828,173
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Ew Healthcare Partners, Itochu Technology Ventures, Kaiser Permanente Ventures, Medtronic, Others
|
||||||
08/15/2008 | Series C | $34.02MM | $xx.xx | $8.26B | Adams Street Partners, Affinity Capital Management, Ew Heathcare Partners, Pacesetter Capital, Spring Ridge Ventures, The Carlyle Group | |
Price per Share
$xx.xx
Shares Outstanding
17,011,801
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Affinity Capital Management, Ew Heathcare Partners, Pacesetter Capital, Spring Ridge Ventures, The Carlyle Group
|
||||||
06/23/2004 | Series B | $11.03MM | $xx.xx | $1.67B | Adam Street Partners, Asset Management Ventures, Fletcher Spaght Ventures, Kaiser Permanente Ventures, Others, Spring Ridge Ventures | |
Price per Share
$xx.xx
Shares Outstanding
12,255,556
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adam Street Partners, Asset Management Ventures, Fletcher Spaght Ventures, Kaiser Permanente Ventures, Others, Spring Ridge Ventures
|
||||||
12/16/2003 | Series A | $750,000.00 | $xx.xx | $300MM | Asset Management Ventures & Spring Ridge Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,500,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.5%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Asset Management Ventures & Spring Ridge Ventures
|